Siegfried Schmitt, PhD, vice-president, Technical at Parexel, answers questions on the use and benefits of real-world ...

Pharma news on AI's role in drug development, new FDA/EMA guidance, clinical advances, MFN pricing agreements, and ongoing quality control challenges.

Pharmaceutical Technology® spoke with Juliana Maynard, PhD, Head of Translational Imaging, at Medicines Discovery Catapult, ...

Pfizer re-balances weight loss portfolio with Metsera, Bristol Myers Squibb and Roche make Breast cancer progress, and ...

In this continuation of a three-part series, the author explores the potential use of agentic AI in pharmaceutical R&D.

AI and ML enhance drug discovery by rapidly screening compounds and predicting ADMET properties, reducing resource commitment ...

Sept. 30 marked 61 days since July 31, one day past the timeframe President Donald Trump had set forth for companies to lower ...

The 100% tariff on imported drugs will pressure pharma companies to build manufacturing sites in the US or face significant ...

Alvin Jogasuria, ProBio; Matthew Lunning, University of Nebraska Medical Center; and Carl Schoellhammer, DeciBio, go behind ...

AI and ML tools are enhancing data management and process control in bio/pharmaceutical manufacturing, with early adoption in ...

This review of the nitrosamines contamination problem in pharmaceuticals takes a look at how the crisis started and developed.

Pharmaceutical Technology® spoke with Bryan Miller, Director of Scientific and Technical Operations at Crown Bioscience UK, ...